Fawziya Abikar Nur | |
---|---|
Minister for Health and Social Care | |
Assumed office 21 March 2017 | |
Prime Minister | Hassan Ali Khaire |
Personal details | |
Nationality | Somalia |
Education | |
Occupation | politician |
Fawziya Abikar Nur (Somali : Foosiya Abiikar Nuur) is the Somalian Federal Minister for Health and Social Care since March 2017. She is trained in law and public health and previously worked for the World Health Organization. She was in the post during the outbreak of the COVID-19 pandemic in Somalia and the arrival of the first vaccines.
She studied law at the Somali National University and in February 1985 she graduated. She then went to Italy where she completed a two-year fellowship in public law at the University of Bologna. She stayed in Italy and studied further at the Istituto Superiore di Sanità in Rome where she gained a master's degree in Health Services Management before she completed a doctorate at the Sapienza University of Rome in public health. [1]
She worked at Somali National University as an assistant lecturer and later on poverty reduction training programmes at Sapienza and the Istituto Superiore di Sanità. From 2012 to 2016, she worked as a consultant for the World Health Organization in Somalia. [1]
On 21 March 2017 she became the Somalian Federal Minister for Health and Social Care and joined Prime Minister Hassan Ali Khaire's new cabinet. [2] The Ministry of Health is based in Mogadishu. [3]
In 2018 she spoke of her country's success in combating cholera and polio. [4]
In April 2020, the first COVID-19 pandemic deaths in Somalia were recorded. Nur announced the death of the first victim who was a 58-year-old man. The second victim was Khalif Mumin Tohow who was a Minister of Justice for the Somalian State of Hirshabelle. [5] He had just returned from a visit to the United Kingdom. [5]
On 8 April 2021, the official death toll from COVID-19 pandemic was 576. On 11 April 2021, the minister received the first coronavirus vaccines from China. [6] The 200,000 doses of the Sinopharm BIBP vaccine were handed over by Chinese ambassador Qin Jian. [6] Ten days later, Somalia received 300,000 doses of the Oxford-AstraZeneca vaccine from the COVAX initiative; [6] Nur said that the vaccine would be sent to every region of Somalia and priority would be given to health care workers during the mass vaccination programme. [6]
In April she also announced that the World Health Organization would be leading improvements in mental health provision. The project is targeting young Somalians who have been affected by conflict. There is little provision for mental health in a country where two-thirds of the population are below thirty years old and many have had to live with violence. [7]
Carlo Maria Petrini is an Italian scientist and bio-ethicist. He is Director of the Bioethics Unit and Chair of the Ethics Committee for clinical trials of Public Research Bodies (EPR) and other Public Bodies at the national level (CEN-NEC) at the Italian National Institute of Health ,as well as the President of the National Coordination Center of Ethics Committees. His work focuses on advancing bioethical standards in scientific research, with particular attention to the ethical implications of medical advancements, clinical trials, and data handling.
The COVID-19 pandemic was confirmed to have reached Somalia on 16 March 2020 when the first case was confirmed in Mogadishu. The Somali Prime Minister, Hassan Ali Khaire announced that the government has set aside five million dollars to deal with the disease. The Somali Medical Association is concerned that the death toll in the country will be huge and that Somalia will not be able to recover from the economic effects due to poor working relations between central government and federal states which leads to lack of control by central government, as well and the lack of healthcare infrastructure. It has also been speculated that President Mohamed Abdullahi Mohamed may use the pandemic as an excuse to postpone elections. There have also been concerns over freedom of the press following arrests and intimidation of journalists who have been covering the pandemic in Somalia.
The COVID-19 pandemic in Papua New Guinea is part of the worldwide pandemic of coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2. The virus was confirmed to have reached Papua New Guinea on 20 March 2020. On 4 May 2020, Papua New Guinea was declared COVID-19 free. However, on 20 June, the government confirmed another case of COVID-19, meaning that the disease was present again within the country.
The COVID-19 pandemic in Belize is part of the ongoing worldwide pandemic of coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2. The virus was confirmed to have reached Belize on 23 March 2020.
The COVID-19 pandemic in Vanuatu is part of the ongoing worldwide pandemic of coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2. The virus was confirmed to have reached Vanuatu on 11 November 2020.
The COVID-19 pandemic in the Isle of Man is part of the worldwide pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The virus was confirmed to have reached the British crown dependency of the Isle of Man on 19 March 2020, when a man returning from Spain via Liverpool tested positive. Community transmission was first confirmed on 22 March on the island.
Khalif Mumin Tohow was a Somali politician. Tohow served as the state Justice Minister for Hirshabelle State, an autonomous region within Somalia, until his death in April 2020. He was also a member of the Legislative Assembly of Hirshabelle State.
The following is a timeline of the COVID-19 pandemic in Canada:
Vaccine diplomacy, a form of medical diplomacy, is the use of vaccines to improve a country's diplomatic relationship and influence of other countries. Meanwhile, vaccine diplomacy also "means a set of diplomatic measures taken to ensure access to the best practices in the development of potential vaccines, to enhance bilateral and/or multilateral cooperation between countries in conducting joint R&D, and, in the case of the announcement of production, to ensure the signing of a contract for the purchase of the vaccine at the shortest term." Although primary discussed in the context of the supply of COVID-19 vaccines, it also played a part in the distribution of the smallpox vaccine.
COVID-19 Vaccines Global Access, abbreviated as COVAX, is a worldwide initiative aimed at equitable access to COVID-19 vaccines directed by the GAVI vaccine alliance, the Coalition for Epidemic Preparedness Innovations (CEPI), and the World Health Organization (WHO), alongside key delivery partner UNICEF. It is one of the four pillars of the Access to COVID-19 Tools Accelerator, an initiative begun in April 2020 by the WHO, the European Commission, and the government of France as a response to the COVID-19 pandemic. COVAX coordinates international resources to enable low-to-middle-income countries equitable access to COVID-19 tests, therapies, and vaccines. UNICEF is the key delivery partner, leveraging its experience as the largest single vaccine buyer in the world and working on the procurement of COVID-19 vaccine doses, as well as logistics, country readiness and in-country delivery.
The Sinopharm BIBP COVID-19 vaccine, also known as BBIBP-CorV, the Sinopharm COVID-19 vaccine, or BIBP vaccine, is one of two whole inactivated virus COVID-19 vaccines developed by Sinopharm's Beijing Institute of Biological Products. It completed Phase III trials in Argentina, Bahrain, Egypt, Morocco, Pakistan, Peru, and the United Arab Emirates (UAE) with over 60,000 participants. BBIBP-CorV shares similar technology with CoronaVac and Covaxin, other inactivated virus vaccines for COVID-19. Its product name is SARS-CoV-2 Vaccine, not to be confused with the similar product name of CoronaVac.
On 22 February 2021, Zimbabwe launched their national COVID-19 vaccination program using the Sinopharm BIBP vaccine. As of 17 June 2022, 6,260,228 people have received their first dose, 4,598,703 have received their second dose, and 851,874 have received a third dose.
The COVID-19 vaccination in Morocco is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.
COVID-19 vaccination programs are ongoing in the majority countries and territories in Africa, with 51 of 54 African countries having launched vaccination programs by July 2021. As of October 2023, 51.8% of the continent's population is fully vaccinated with over 1084.5 million doses administered.
COVID-19 vaccination in Sri Lanka is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, in response to the ongoing pandemic in the country. As of late July, the Sinopharm BIBP vaccine accounted for 78% of the total 13.8 million vaccines obtained by Sri Lanka to date. The United States donated over 1.5 million Moderna vaccine through COVAX.
COVID-19 vaccination in Burundi is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country. Burundi was one of the last nation states in the world to commence vaccination against COVID-19. This was mostly due to the government's refusal to vaccinate the population throughout most of 2021. In February 2021, Thaddee Ndikumana, the health minister of Burundi, said his country was more concerned with prevention measures. "Since more than 95% of patients are recovering, we estimate that the vaccines are not yet necessary," local media reported.
COVID-19 vaccination in Egypt is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.
COVID-19 vaccination in Equatorial Guinea is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.
COVID-19 vaccination in Comoros is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.